Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.

Busson R, van der Kaaij M, Mounier N, Aleman BMP, Thiéblemont C, Stamatoullas A, Ribrag V, Tilly H, Haioun C, Casasnovas RO, Kluin-Nelemans HC, Henry-Amar M.

Health Qual Life Outcomes. 2019 Jul 2;17(1):115. doi: 10.1186/s12955-019-1186-x.

2.

Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.

Mounier N, Anthony S, Busson R, Thieblemont C, Ribrag V, Tilly H, Haioun C, Casasnovas RO, Morschhauser F, Feugier P, Delarue R, Ysebaert L, Sebban C, Broussais-Guillaumot F, Damaj G, Nerich V, Jais JP, Laborde L, Salles G, Henry-Amar M.

Cancer. 2019 Mar 22. doi: 10.1002/cncr.32040. [Epub ahead of print]

PMID:
30901086
3.

Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.

Thomas J, Fermé C, Noordijk EM, Morschhauser F, Girinsky T, Gaillard I, Lugtenburg PJ, André M, Lybeert MLM, Stamatoullas A, Beijert M, Hélias P, Eghbali H, Gabarre J, van der Maazen RWM, Jaubert J, Bouabdallah K, Boulat O, Roesink JM, Christian B, Ong F, Bordessoule D, Tertian G, Gonzalez H, Vranovsky A, Quittet P, Tirelli U, de Jong D, Audouin J, Aleman BMP, Henry-Amar M.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1133-1145. doi: 10.1016/j.ijrobp.2017.10.015. Epub 2017 Oct 27.

PMID:
29229324
4.

Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials.

Eichenauer DA, Becker I, Monsef I, Chadwick N, de Sanctis V, Federico M, Fortpied C, Gianni AM, Henry-Amar M, Hoskin P, Johnson P, Luminari S, Bellei M, Pulsoni A, Sydes MR, Valagussa P, Viviani S, Engert A, Franklin J.

Haematologica. 2017 Oct;102(10):1748-1757. doi: 10.3324/haematol.2017.167478. Epub 2017 Sep 14. Review.

5.

Differential distribution of vapA-positive Rhodococcus equi in affected and unaffected horse-breeding farms.

Petry S, Sévin C, Fleury MA, Duquesne F, Foucher N, Laugier C, Henry-Amar M, Tapprest J.

Vet Rec. 2017 Aug 5;181(6):145. doi: 10.1136/vr.104088. Epub 2017 Jun 22. No abstract available.

PMID:
28642343
6.

ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.

Fermé C, Thomas J, Brice P, Casasnovas O, Vranovsky A, Bologna S, Lugtenburg PJ, Bouabdallah R, Carde P, Sebban C, Eghbali H, Salles G, van Imhoff GW, Thyss A, Noordijk EM, Reman O, Lybeert MLM, Janvier M, Spina M, Audhuy B, Raemaekers JMM, Delarue R, Anglaret B, de Weerdt O, Marjanovic Z, Tersteeg RJHA, de Jong D, Brière J, Henry-Amar M; European Organisation for Research and Treatment of Cancer Lymphoma Group, and; Groupe d'Étude des Lymphomes de l'Adulte.

Eur J Cancer. 2017 Aug;81:45-55. doi: 10.1016/j.ejca.2017.05.005. Epub 2017 Jun 8.

PMID:
28601705
7.

[Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment].

Anthony S, Hebel P, Garrel A, Oliveri V, Thieblemont C, Ribrag V, Tilly H, Haioun C, Casasnovas RO, Morschhauser F, Feugier P, Delarue R, Ysebaert L, Sebban C, Broussais F, Damaj G, Nerich V, Jais JP, Salles G, Henry-Amar M, Mounier N.

Bull Cancer. 2017 Mar;104(3):221-231. doi: 10.1016/j.bulcan.2017.01.007. Epub 2017 Feb 15. French.

PMID:
28214006
8.

Does persistent fatigue in survivors relate to cancer?

Henry-Amar M, Busson R.

Lancet Oncol. 2016 Oct;17(10):1351-1352. doi: 10.1016/S1470-2045(16)30156-5. Epub 2016 Sep 6. No abstract available.

PMID:
27612584
9.

Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.

Maraldo MV, Giusti F, Vogelius IR, Lundemann M, van der Kaaij MA, Ramadan S, Meulemans B, Henry-Amar M, Aleman BM, Raemaekers J, Meijnders P, Moser EC, Kluin-Nelemans HC, Feugier P, Casasnovas O, Fortpied C, Specht L; European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group.

Lancet Haematol. 2015 Nov;2(11):e492-502. doi: 10.1016/S2352-3026(15)00153-2. Epub 2015 Oct 22.

PMID:
26686259
10.

Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study.

van der Kaaij MA, van Echten-Arends J, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Eghbali H, Brice P, Smit WG, Sebban C, Doorduijn JK, Roesink JM, Gaillard I, Coiffier B, Lybeert ML, Casasnovas O, André M, Raemaekers JM, Henry-Amar M, Kluin-Nelemans JC; European Organisation for Research and Treatment of Cancer Lymphoma Group and the Groupe d’Étude des Lymphomes de l'Adulte.

Hum Reprod. 2014 Mar;29(3):525-33. doi: 10.1093/humrep/det430. Epub 2013 Dec 17.

PMID:
24345581
11.

Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study.

van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser LC, Allgeier A, Meulemans B, Dubois B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Doorduijn JK, Sebban C, Smit WG, Bologna S, Roesink JM, Ong F, André MP, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC.

J Clin Oncol. 2012 Nov 1;30(31):3854-63. doi: 10.1200/JCO.2011.40.8906. Epub 2012 Sep 24.

PMID:
23008303
12.

Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study.

van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Bologna S, Ong F, Eghbali H, Doorduijn JK, Morschhauser F, Sebban C, Roesink JM, Bouteloup M, Van Hoof A, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC.

J Clin Oncol. 2012 Jan 20;30(3):291-9. doi: 10.1200/JCO.2011.37.1989. Epub 2011 Dec 19.

PMID:
22184372
13.

Health-related quality of life among long-term survivors of colorectal cancer: a population-based study.

Caravati-Jouvenceaux A, Launoy G, Klein D, Henry-Amar M, Abeilard E, Danzon A, Pozet A, Velten M, Mercier M.

Oncologist. 2011;16(11):1626-36. doi: 10.1634/theoncologist.2011-0036. Epub 2011 Oct 10.

14.

Long-term quality of life after breast cancer: a French registry-based controlled study.

Klein D, Mercier M, Abeilard E, Puyraveau M, Danzon A, Dalstein V, Pozet A, Guizard AV, Henry-Amar M, Velten M.

Breast Cancer Res Treat. 2011 Aug;129(1):125-34. doi: 10.1007/s10549-011-1408-3. Epub 2011 Feb 22.

PMID:
21340477
15.

One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer.

Noal S, Levy C, Hardouin A, Rieux C, Heutte N, Ségura C, Collet F, Allouache D, Switsers O, Delcambre C, Delozier T, Henry-Amar M, Joly F.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):795-803. doi: 10.1016/j.ijrobp.2010.06.037. Epub 2010 Oct 1.

PMID:
20888704
16.

Association of pegylated liposomal doxorubicin and ifosfamide in early recurrent ovarian cancer patients: a multicenter phase II trial.

Joly F, Sevin E, Lortholary A, Priou F, Paitel JF, Fabbro M, Henry-Amar M, Hamond K, Bourgeois H.

Gynecol Oncol. 2010 Mar;116(3):312-6. doi: 10.1016/j.ygyno.2009.09.036. Epub 2009 Nov 3.

PMID:
19887304
17.

Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials.

van der Kaaij MA, Heutte N, van Echten-Arends J, Raemaekers JM, Carde P, Noordijk EM, Fermé C, Thomas J, Eghbali H, Brice P, Bonmati C, Henry-Amar M, Kluin-Nelemans HC.

Haematologica. 2009 Dec;94(12):1691-7. doi: 10.3324/haematol.2009.009696. Epub 2009 Oct 22.

18.

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

Heutte N, Flechtner HH, Mounier N, Mellink WA, Meerwaldt JH, Eghbali H, van't Veer MB, Noordijk EM, Kluin-Nelemans JC, Lampka E, Thomas J, Lugtenburg PJ, Viterbo L, Carde P, Hagenbeek A, van der Maazen RW, Smit WG, Brice P, van Marwijk Kooy M, Baars JW, Poortmans P, Tirelli U, Leeksma OC, Tomsic R, Feugier P, Salles G, Gabarre J, Kersten MJ, Van Den Neste E, Creemers GJ, Gaillard I, Meijnders P, Tertian G, Reman O, Muller HP, Troncy J, Blanc M, Schroyens W, Voogt PJ, Wijermans P, Rieux C, Fermé C, Henry-Amar M; EORTC-GELA H8 Trial Group.

Lancet Oncol. 2009 Dec;10(12):1160-70. doi: 10.1016/S1470-2045(09)70258-X. Epub 2009 Oct 12.

PMID:
19828373
19.

Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II study.

Joly F, Petit T, Pautier P, Guardiola E, Mayer F, Chevalier-Place A, Delva R, Sevin E, Henry-Amar M, Bourgeois H.

Gynecol Oncol. 2009 Dec;115(3):382-8. doi: 10.1016/j.ygyno.2009.08.024. Epub 2009 Sep 20.

PMID:
19773043
20.

Do patients with advanced urothelial carcinoma benefit from weekly paclitaxel chemotherapy? A GETUG phase II study.

Joly F, Houédé N, Noal S, Chevreau C, Priou F, Chinet-Charrot P, Rolland F, Fléchon A, Henry-Amar M, Culine S.

Clin Genitourin Cancer. 2009 Aug;7(2):E28-33. doi: 10.3816/CGC.2009.n.018.

PMID:
19692319
21.

Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer.

Aide N, Heutte N, Rame JP, Rousseau E, Loiseau C, Henry-Amar M, Bardet S.

J Clin Endocrinol Metab. 2009 Jun;94(6):2075-84. doi: 10.1210/jc.2008-2313. Epub 2009 Mar 10.

PMID:
19276233
22.

Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer.

Garsi JP, Schlumberger M, Ricard M, Labbé M, Ceccarelli C, Schvartz C, Henry-Amar M, Bardet S, Rubino C, De Vathaire F.

Clin Endocrinol (Oxf). 2009 Dec;71(6):880-3. doi: 10.1111/j.1365-2265.2009.03561.x. Epub 2009 Feb 25.

PMID:
19250267
23.

Prognostic significance of tumour vascularisation on survival of patients with advanced ovarian carcinoma.

Labiche A, Elie N, Herlin P, Denoux Y, Crouet H, Heutte N, Joly F, Héron JF, Gauduchon P, Henry-Amar M.

Histol Histopathol. 2009 Apr;24(4):425-35. doi: 10.14670/HH-24.425.

PMID:
19224445
24.

Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials.

Favier O, Heutte N, Stamatoullas-Bastard A, Carde P, Van't Veer MB, Aleman BM, Noordijk EM, Thomas J, Fermé C, Henry-Amar M; European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group and the Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

Cancer. 2009 Apr 15;115(8):1680-91. doi: 10.1002/cncr.24178.

25.

Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphoma.

Haas RL, Girinsky T, Aleman BM, Henry-Amar M, de Boer JP, de Jong D.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1199-202. doi: 10.1016/j.ijrobp.2008.09.049. Epub 2009 Jan 7.

PMID:
19131186
26.

Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma.

Bardet S, Malville E, Rame JP, Babin E, Samama G, De Raucourt D, Michels JJ, Reznik Y, Henry-Amar M.

Eur J Endocrinol. 2008 Apr;158(4):551-60. doi: 10.1530/EJE-07-0603.

PMID:
18362303
27.

Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.

Racadot S, Mercier M, Dussart S, Dessard-Diana B, Bensadoun RJ, Martin M, Malaurie E, Favrel V, Housset M, Durdux C, Journel C, Calais G, Huet J, Pillet G, Hennequin C, Haddad E, Diana C, Blaska-Jaulerry B, Henry-Amar M, Géhanno P, Baillet F, Mazeron JJ.

Radiother Oncol. 2008 May;87(2):164-72. doi: 10.1016/j.radonc.2007.12.021. Epub 2008 Jan 25.

PMID:
18222010
28.

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

Fermé C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, Girinsky T, Brice P, van't Veer MB, Walewski JA, Lederlin P, Tirelli U, Carde P, Van den Neste E, Gyan E, Monconduit M, Diviné M, Raemaekers JM, Salles G, Noordijk EM, Creemers GJ, Gabarre J, Hagenbeek A, Reman O, Blanc M, Thomas J, Vié B, Kluin-Nelemans JC, Viseu F, Baars JW, Poortmans P, Lugtenburg PJ, Carrie C, Jaubert J, Henry-Amar M; EORTC-GELA H8 Trial.

N Engl J Med. 2007 Nov 8;357(19):1916-27.

29.

[Prognostic factors of localised, locally advanced or metastatic prostate cancer].

Joly F, Henry-Amar M.

Bull Cancer. 2007 Jul;94(7 Suppl):F35-43. Review. French.

PMID:
17845992
30.

Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.

van der Kaaij MA, Heutte N, Le Stang N, Raemaekers JM, Simons AH, Carde P, Noordijk EM, Fermé C, Thomas J, Eghbali H, Kluin-Nelemans HC, Henry-Amar M; European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group; Groupe d'Etude des Lymphomes de l'Adulte.

J Clin Oncol. 2007 Jul 1;25(19):2825-32. Epub 2007 May 21.

PMID:
17515571
31.

Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.

Aleman BM, Raemaekers JM, Tomiŝiĉ R, Baaijens MH, Bortolus R, Lybeert ML, van der Maazen RW, Girinsky T, Demeestere G, Lugtenburg P, Lievens Y, de Jong D, Pinna A, Henry-Amar M; European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group.

Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):19-30. Epub 2006 Nov 9.

PMID:
17097834
32.

Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma.

Michels JJ, Jacques M, Henry-Amar M, Bardet S.

Hum Pathol. 2007 Feb;38(2):212-9. Epub 2006 Nov 13.

PMID:
17097131
33.

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.

Franklin J, Pluetschow A, Paus M, Specht L, Anselmo AP, Aviles A, Biti G, Bogatyreva T, Bonadonna G, Brillant C, Cavalieri E, Diehl V, Eghbali H, Fermé C, Henry-Amar M, Hoppe R, Howard S, Meyer R, Niedzwiecki D, Pavlovsky S, Radford J, Raemaekers J, Ryder D, Schiller P, Shakhtarina S, Valagussa P, Wilimas J, Yahalom J.

Ann Oncol. 2006 Dec;17(12):1749-60. Epub 2006 Sep 19.

PMID:
16984979
34.

Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.

Noordijk EM, Carde P, Dupouy N, Hagenbeek A, Krol AD, Kluin-Nelemans JC, Tirelli U, Monconduit M, Thomas J, Eghbali H, Aleman BM, Bosq J, Vovk M, Verschueren TA, Pény AM, Girinsky T, Raemaekers JM, Henry-Amar M.

J Clin Oncol. 2006 Jul 1;24(19):3128-35. Epub 2006 Jun 5.

PMID:
16754934
35.

Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera.

Andrieux A, Switsers O, Chajari MH, Jacob JH, Delozier T, Gervais R, Allouache N, Laurençon V, Henry-Amar M, Bardet S.

Q J Nucl Med Mol Imaging. 2006 Mar;50(1):68-77.

36.

Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entity.

de Jong D, Bosq J, MacLennan KA, Diebold J, Audouin J, Chasle J, Mandard AM, Marnay J, Henry-Amar M; European Oranization for Research and Treatment of Cancer Lyphoma Group; Groupe d'Etude des Lymphomes de l'Adulte.

Ann Oncol. 2006 Jan;17(1):141-5. Epub 2005 Nov 10.

PMID:
16284059
37.

Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).

Aleman BM, Girinsky T, van der Maazen RW, Strijk S, Meijnders P, Bortolus R, Olofsen-van Acht MJ, Lybeert ML, Lievens Y, Eghbali H, Noordijk EM, Tomsic R, Meerwaldt JH, Poortmans PM, Smit WG, Pinna A, Henry-Amar M, Raemaekers JM; European Organization for Research; Treatment of Cancer (EORTC) Lymphoma Group.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1184-90. Epub 2005 Jun 2.

PMID:
15936157
38.

Expression of alpha V-associated integrin beta subunits in epithelial ovarian cancer and its relation to prognosis in patients treated with platinum-based regimens.

Maubant S, Cruet-Hennequart S, Dutoit S, Denoux Y, Crouet H, Henry-Amar M, Gauduchon P.

J Mol Histol. 2005 Feb;36(1-2):119-29.

PMID:
15704006
39.

Radiotherapy in advanced-stage Hodgkin's lymphoma.

Raemaekers JM, Aleman BM, Henry-Amar M.

J Clin Oncol. 2005 Jan 1;23(1):245-6; author reply 246. No abstract available.

PMID:
15625384
40.

Risk of second primary cancer following differentiated thyroid cancer.

Berthe E, Henry-Amar M, Michels JJ, Rame JP, Berthet P, Babin E, Icard P, Samama G, Galateau-Sallé F, Mahoudeau J, Bardet S.

Eur J Nucl Med Mol Imaging. 2004 May;31(5):685-91. Epub 2004 Jan 28.

PMID:
14747959
41.

Urine mutagenicity and lymphocyte DNA damage in fruit growers occupationally exposed to the fungicide captan.

Lebailly P, Devaux A, Pottier D, De Meo M, Andre V, Baldi I, Severin F, Bernaud J, Durand B, Henry-Amar M, Gauduchon P.

Occup Environ Med. 2003 Dec;60(12):910-7.

42.

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.

André M, Mounier N, Leleu X, Sonet A, Brice P, Henry-Amar M, Tilly H, Coiffier B, Bosly A, Morel P, Haioun C, Gaulard P, Reyes F, Gisselbrecht C; Groupe D'Etude Des Lymphomes De L'Adulte.

Blood. 2004 Feb 15;103(4):1222-8. Epub 2003 Oct 23.

43.

Involved-field radiotherapy for advanced Hodgkin's lymphoma.

Aleman BM, Raemaekers JM, Tirelli U, Bortolus R, van 't Veer MB, Lybeert ML, Keuning JJ, Carde P, Girinsky T, van der Maazen RW, Tomsic R, Vovk M, van Hoof A, Demeestere G, Lugtenburg PJ, Thomas J, Schroyens W, De Boeck K, Baars JW, Kluin-Nelemans JC, Carrie C, Aoudjhane M, Bron D, Eghbali H, Smit WG, Meerwaldt JH, Hagenbeek A, Pinna A, Henry-Amar M; European Organization for Research and Treatment of Cancer Lymphoma Group.

N Engl J Med. 2003 Jun 12;348(24):2396-406.

44.

BCL-2/JH translocation in peripheral blood lymphocytes of unexposed individuals: lack of seasonal variations in frequency and molecular features.

Roulland S, Lebailly P, Roussel G, Briand M, Cappellen D, Pottier D, Hardouin A, Troussard X, Bastard C, Henry-Amar M, Gauduchon P.

Int J Cancer. 2003 May 10;104(6):695-8.

45.

Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance.

Michels JJ, Duigou F, Marnay J, Henry-Amar M, Delozier T, Denoux Y, Chasle J.

Cancer. 2003 Mar 15;97(6):1376-86.

46.

Urine mutagenicity of farmers occupationally exposed during a 1-day use of chlorothalonil and insecticides.

André V, Lebailly P, Pottier D, Deslandes E, De Méo M, Henry-Amar M, Gauduchon P.

Int Arch Occup Environ Health. 2003 Feb;76(1):55-62. Epub 2002 Oct 2.

PMID:
12592583
47.

Biomonitoring of urine mutagenicity with the Ames test: improvement of the extraction/concentration method.

Andre V, Lebailly P, Deslandes E, Henry-Amar M, Gauduchon P.

Mutat Res. 2002 Sep 26;520(1-2):199-205.

PMID:
12297160
48.

[Bone mineral density and biological markers of bone repair in patients with adrenal incidentaloma: effect of subclinical hypercortisolism].

Bardet S, Rohmer V, Boux de Casson F, Coffin C, Ronci N, Sabatier JP, Lecomte P, Audran M, Henry-Amar M, Tabarin A.

Rev Med Interne. 2002 Jun;23(6):508-17. French.

PMID:
12108175
49.

Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?

Chajari M, Lacroix J, Peny AM, Chesnay E, Batalla A, Henry-Amar M, Delcambre C, Génot JY, Fruchard C, Bardet S.

Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):380-7.

PMID:
12002715
50.

The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer.

Raemaekers J, Kluin-Nelemans H, Teodorovic I, Meerwaldt C, Noordijk E, Thomas J, Glabbeke Mv, Henry-Amar M, Carde P.

Eur J Cancer. 2002 Mar;38 Suppl 4:S107-13.

PMID:
11858975

Supplemental Content

Loading ...
Support Center